34
J. Su¨ltemeyer et al. / Journal of Organometallic Chemistry 606 (2000) 26–36
OCH2CH2CH2CH, OCH2CH2CH2CH%), 6.15 (dq,
OCH2CH%) 144.89 (OCCHCH, OCCHCH%), 165.72
(CO,CO%) ppm. FABMS: m/z: 225 [M++H]. 5H-fu-
ran-2-one 22. Yield: 7 mg (0,08 mmol, 8%). The analyt-
ical data for 22 correspond to the data given in
literature [31].
3
3JE=14.8, J=7.0 Hz, 2H, CHCHCH3, CHCHCH3%),
3
7.19 (d, JE=14.8, 2H, CHCHCH3) ppm. 13C-NMR
(125 MHz, C6D6): l 17.70 (CH3, CH3%), 28.91 (2×
CH2), 29.03 (2×CH2), 79.44 (CH2O, CH2O%), 128.29
(CHCHCH3, CHCHCH%3), 130.09 (OCH2CH2CH2CH,
OCH2CH2CH2CH%), 145.63 (CHCHCH3, CHCH-
CH3‘), 217.23 (cis-CO, cis-CO%), 224.14 (trans-CO,
Metathesis of butenylcrotonate (20): 1,6-bis-E-
crotonyloxy-hex-3-ene (26): Yield: 151 mg (0.6 mmol,
60%); E/Z-ratio: 1.8:1. Rf=0.6 (petroleum ether/di-
ethyl ether (3:1)). E-isomer: 1H-NMR (250 MHz, C6D6):
1
trans-CO%), 333.80 (CrꢁC, CrꢁC%) ppm. Z-isomer: H-
3
4
3
4
NMR (500 MHz, C6D6): l 1.36 (dd, J=7.0, J=1.6
l 1.40 (dd, J=6.9, J=1.5 Hz, 6H, CH3, CH3%), 2.20
Hz, 6H, CH3, CH3%), 1.63 (tt, 3J=6.5 Hz, 4H,
(m, 4H, OCH2CH2, OCH2CH%), 4.07 (t, J=6.7 Hz,
3
2
3
4
OCH2CH2, OCH2CH%), 1.98–2.06 (m, 4H, OCH2-
4H, OCH2, OCH%2), 5.31 (tt, J=4.0, J=1.5 Hz, 2H,
2
CH2CH2, OCH2CH2CH%), 4.61 (t, 3J=6.4 Hz, 4H,
OCH2CH2CH, OCH2CH2CH%), 5.83 (dq, 3JE=15.0,
2
OCH2, OCH%), 5.35 (tt, 3J=4.8, 4J=1.2 Hz, 2H,
4J=1.5 Hz, 2H, CCHCH, CCHCH‘), 6.95 (dq, JE=
3
2
3
OCH2CH2CH2CH, OCH2CH2CH2CH%), 6.15 (dq,
15.0, J=6.9 Hz, 2H, CCHCH, CCHCH%) ppm. 13C-
3
3JE=14.8, J=7.0 Hz, 2H, CHCHCH3, CHCHCH3%),
NMR (62.5 MHz, C6D6): l 17.53 (CH3, CH3%), 32.41
(OCH2CH2, OCH2CH2%), 63.49 (OCH2, OCH2%), 123.12
(CCHCH, CCHCH%), 128.56 (OCH2CH2CH, OCH2-
CH2CH%), 144.28 (CCHCH, CCHCH%), 165.92 (CO,
CO%) ppm. Z-isomer: 1H-NMR (250 MHz, C6D6): l
3
7.17 (d, JE=14.8, 2H, CHCHCH3) ppm. 13C-NMR
(125 MHz, C6D6): l 17.70 (CH3, CH3%), 23.69 (2×
CH2), 29.13 (2×CH2), 79.34 (CH2O, CH2O%), 128.29
(CHCHCH3, CHCHCH%3), 129.48 (OCH2CH2CH2CH,
OCH2CH2CH2CH%), 145.71 (CHCHCH3, CHCHCH%3),
217.36 (cis-CO, cis-CO%), 224.17 (trans-CO, trans-CO%),
333.93 (CrꢁC, CrꢁC%) ppm. FABMS: m/z: 632 [M+],
492 [M+−5CO], 408 [M+−8CO], 380 [M+−9CO],
352 [M+−10CO]. 110 mg (0.34 mml, 67%) of starting
material 15 were reisolated.
1.40 (dd, 3J=6.9, 4J=1.5 Hz, 6H, CH3, CH3%), 2.20 (m,
3
4H, OCH2CH2, OCH2CH%), 4.07 (t, J=6.7 Hz, 4H,
2
OCH2, OCH%2), 5.39 (tt, 3J=5.0, 4J=1.2 Hz, 2H,
OCH2CH2CH, OCH2CH2CH%), 5.83 (dq, 3JE=15.0,
4J=1.5 Hz, 2H, CCHCH, CCHCH%), 6.95 (dq, JE=
3
15.0, J=6.9 Hz, 2H, CCHCH, CCHCH%) ppm. 13C-
3
General procedure for the metathesis of the alkenyl
crotonates 19–21: 41 mg (5 mol%) of catalyst 7 were
added at r.t. to a solution of 1 mmol alkenyl crotonate
in 100 ml dichloromethane. The reaction mixture was
stirred for 3 h before additional 41 mg (5 mol%) 7 were
added. After 3 h the solvent was evaporated, and
chromatographic work-up using petroleum ether/di-
ethyl ether (3:1) afforded the products as colourless
oils.
NMR (62.5 MHz, C6D6): l 17.53 (CH3, CH3%), 27.21
(OCH2CH2, OCH2CH2%), 63.38 (OCH2, OCH2%), 123.12
(CCHCH,
CCHCH%),
128.56
(OCH2CH2CH,
OCH2CH2CH%), 144.36 (CCHCH, CCHCH%), 165.92
(CO, CO%) ppm. FABMS: m/z: 253 [M++H], 167
[M++H, ꢀC4O2H6]. 5,6-Dihydro-pyran-2-one (23).
Yield: 15 mg (0.15 mmol, 15%). The analytical data for
23 correspond to the data given in literature [32]
Metathesis of butenylcrotonate (21): 1,8-bis-E-
crotonyloxy-oct-4-ene (27): Yield: 193 mg (0.69 mmol,
69%); E/Z-ratio: 3:1. Rf=0.6 (petroleum ether/diethyl
Metathesis of allylcrotonate (19): 1,4-bis-E-crotonyl-
oxy-but-2-ene (25): Yield: 90 mg (0.4 mmol, 40%);
E/Z-ratio: 5:1. Rf=0.6 (petroleum ether/diethyl ether
1
ether (3:1)). E-isomer: H-NMR (500 MHz, C6D6): l
1
3
4
(3:1)). E-isomer: H-NMR (500 MHz, C6D6): l 1.34
1.38 (dd, J=6.7, J=1.5 Hz, 6H, CH3, CH3%), 1.57 (tt,
3
4
3
(dd, J=7.0, J=1.5 Hz, 6H, CH3, CH3%), 4.50 (dd,
3J=6.8 Hz, 4H, OCH2CH2, OCH2CH%), 1.94 (td, J=
2
3J=3.0, 4J=1.5 Hz, 4H, OCH2, OCH%), 5.66 (tt,
6.8, 4.0 Hz, 4H, OCH2CH2CH2, OCH2CH2CH%), 4.13
2
2
3J=3.0, J=1.5 Hz, 2H, OCH2CH2, OCH2CH%), 5.79
(t, J=6.8 Hz, 4H, OCH2, OCH%2), 5.29 (tt, J=4.0,
4
3
3
2
(dq, 3JE=15.0, 4J=1.5 Hz, 2H, CCH, CCH%), 6.93
(dq, 3JE=15.0, 3J=7.0 Hz, 2H, OCCHCH, OC-
CHCH%) ppm. 13C-NMR (125 MHz, C6D6): l 17.68
(CH3, CH3%), 63.75 (OCH2 OCH2%), 122.95 (OCCHCH,
OCCHCH%), 128.43 (OCH2CH, OCH2CH%), 144.89
(OCCHCH, OCCHCH%), 165.72 (CO,CO%) ppm. Z-iso-
4J=1.5 Hz, 2H, OCH2CH2CH2CH, OCH2CH2CH2-
3
4
CH%), 5.85 (dq, JE=15.5, J=1.5 Hz, 2H, CCHCH,
CCHCH%), 6.97 (dq, 3JE=15.5, 3J=6.7 Hz, 2H,
CCHCH, CCHCH%) ppm. 13C-NMR (125 MHz, C6D6):
l 17.5 (CH3, CH3%), 28.84 (2×CH2), 29.15 (2×CH2),
63.51 (OCH2, OCH2%), 123.21 (CCHCH, CCHCH%),
130.07 (OCH2CH2CH2CH, OCH2CH2CH2CH%), 144.20
(CCHCH, CCHCH%), 166.01 (CO, CO%) ppm. Z-iso-
1
3
mer: H-NMR (500 MHz, C6D6): l 1.34 (dd, J=7.0,
4J=1.5 Hz, 6H, CH3, CH3%), 4.67 (dd, J=4.0, J=1.2
Hz, 4H, OCH2, OCH%), 5.62 (tt, J=4.0, J=1.2 Hz,
2H, OCH2CH2, OCH2CH%), 5.79 (dq, JE=15.0, J=
1.5 Hz, 2H, CCH, CCH%), 6.93 (dq, JE=15.0, J=7.0
Hz, 2H, OCCHCH, OCCHCH%) ppm. 13C-NMR (125
MHz, C6D6): l 17.68 (CH3, CH%3), 69.92 (OCH2 OCH%2),
122.95 (OCCHCH, OCCHCH%), 128.58 (OCH2CH,
3
4
3
4
1
3
mer: H-NMR (500 MHz, C6D6): l 1.39 (dd, J=6.7,
2
3
4
3
4J=1.5 Hz, 6H, CH3, CH3%), 1.57 (tt, J=6.8 Hz, 4H,
OCH2CH2, OCH2CH%), 1.20 (td, J=6.8, 4.8 Hz, 4H,
OCH2CH2CH2, OCH2CH2CH%), 4.11 (t, J=6.8 Hz,
2
3
3
3
2
3
2
3
4
4H, OCH2, OCH%2), 5.31 (tt, J=4.8, J=1.2 Hz, 2H,
OCH2CH2CH2CH, OCH2CH2CH2CH%), 5.85 (dq, 3JE=